Feymer(SH:688350)2025-02-27 08:00Financial Performance - Total operating revenue for 2024 was RMB 156.56 million, a decrease of 4.54% compared to RMB 164.01 million in the previous year[5] - The company reported a total profit of RMB -1.31 million, and a net profit attributable to shareholders of RMB -0.49 million, marking a significant decline from RMB 2.72 million in the previous year[5] - Basic earnings per share were RMB -0.04, down from RMB 0.22 in the previous year[6] Assets and Equity - Total assets increased to RMB 2.70 billion, reflecting an 8.44% growth from RMB 2.49 billion at the beginning of the period[9] - Shareholders' equity attributable to the parent company decreased to RMB 1.40 billion, a decline of 6.91% from RMB 1.51 billion at the beginning of the period[9] Challenges and Declines - The decline in performance was attributed to global economic slowdown, weak downstream demand, and increased competition in the industry[9] - The company faced challenges in its chemical business and new product launches, leading to a decrease in sales prices and revenue[9] - Increased financial expenses were noted due to the capitalization of interest from convertible bonds issued in December 2022[9] - The acquisition of Suzhou Jingchang Technology Development Co., Ltd. resulted in a significant goodwill impairment due to losses from its controlled subsidiary[9] - The membrane business underperformed due to reduced investment in environmental projects, impacting revenue growth[9]